Literature DB >> 28119000

Threshold and non-threshold chemical carcinogens: A survey of the present regulatory landscape.

Ruth J Bevan1, Paul T C Harrison2.   

Abstract

For the proper regulation of a carcinogenic material it is necessary to fully understand its mode of action, and in particular whether it demonstrates a threshold of effect. This paper explores our present understanding of carcinogenicity and the mechanisms underlying the carcinogenic response. The concepts of genotoxic and non-genotoxic and threshold and non-threshold carcinogens are fully described. We provide summary tables of the types of cancer considered to be associated with exposure to a number of carcinogens and the available evidence relating to whether carcinogenicity occurs through a threshold or non-threshold mechanism. In light of these observations we consider how different regulatory bodies approach the question of chemical carcinogenesis, looking in particular at the definitions and methodologies used to derive Occupational Exposure Levels (OELs) for carcinogens. We conclude that unless proper differentiation is made between threshold and non-threshold carcinogens, inappropriate risk management measures may be put in place - and lead also to difficulties in translating carcinogenicity research findings into appropriate health policies. We recommend that clear differentiation between threshold and non-threshold carcinogens should be made by all expert groups and regulatory bodies dealing with carcinogen classification and risk assessment.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carcinogen; Classification; Guideline values; Non-threshold; OELs; Regulation; Risk assessment; Threshold

Mesh:

Substances:

Year:  2017        PMID: 28119000     DOI: 10.1016/j.yrtph.2017.01.003

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  4 in total

1.  FREE INVENTORY PLATFORM MANAGES CHEMICAL RISKS, ADDRESSES CHEMICAL ACCOUNTABILITY, AND MEASURES COST-EFFECTIVENESS.

Authors:  Malcolm J D'Souza; Kristopher P Roeske; Lily S Neff
Journal:  Int J Adv Sci Eng Technol       Date:  2017-10-26

2.  Nickel Nanoparticles Induce the Synthesis of a Tumor-Related Polypeptide in Human Epidermal Keratinocytes.

Authors:  Javier Jiménez-Lamana; Simon Godin; Gerard Aragonès; Cinta Bladé; Joanna Szpunar; Ryszard Łobinski
Journal:  Nanomaterials (Basel)       Date:  2020-05-21       Impact factor: 5.076

3.  Derivation of a no-significant-risk-level for tetrabromobisphenol A based on a threshold non-mutagenic cancer mode of action.

Authors:  Alison M Pecquet; Jeanelle M Martinez; Melissa Vincent; Neeraja Erraguntla; Michael Dourson
Journal:  J Appl Toxicol       Date:  2018-02-13       Impact factor: 3.446

Review 4.  Carcinogenicity of Poorly Soluble Low Toxicity Particles: Commentary on Epidemiology as a Risk Assessment "Reality Check".

Authors:  Kenneth A Mundt; Annette B Santamaria; William J Thompson; Christopher A Bates; Corey Boles; G Scott Dotson; Mei Yong
Journal:  Front Public Health       Date:  2022-07-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.